1U0N image
Deposition Date 2004-07-13
Release Date 2005-04-19
Last Version Date 2024-10-30
Entry Detail
PDB ID:
1U0N
Keywords:
Title:
The ternary von Willebrand Factor A1-glycoprotein Ibalpha-botrocetin complex
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Bothrops jararaca (Taxon ID: 8724)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.95 Å
R-Value Free:
0.27
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 41 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Von Willebrand factor
Gene (Uniprot):VWF
Chain IDs:A
Chain Length:208
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Botrocetin
Chain IDs:B
Chain Length:133
Number of Molecules:1
Biological Source:Bothrops jararaca
Polymer Type:polypeptide(L)
Molecule:Botrocetin
Chain IDs:C
Chain Length:125
Number of Molecules:1
Biological Source:Bothrops jararaca
Polymer Type:polypeptide(L)
Molecule:Platelet glycoprotein Ib
Gene (Uniprot):GP1BA
Mutations:N21Q,N159Q
Chain IDs:D
Chain Length:265
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation
Nat.Struct.Mol.Biol. 12 152 159 (2005)
PMID: 15665869 DOI: 10.1038/nsmb892

Abstact

Botrocetin is a snake venom protein that enhances the affinity of the A1 domain of plasma von Willebrand factor (vWF) for the platelet receptor glycoprotein Ibalpha (GPIbalpha), an event that contributes to bleeding and host death. Here we describe a kinetic and crystallographic analysis of this interaction that reveals a novel mechanism of affinity enhancement. Using high-temporal-resolution microscopy, we show that botrocetin decreases the GPIbalpha off-rate two-fold in both human and mouse complexes without affecting the on-rate. The key to this behavior is that, upon binding of GPIbalpha to vWF-A1, botrocetin prebound to vWF-A1 makes no contacts initially with GPIbalpha, but subsequently slides around the A1 surface to form a new interface. This two-step mechanism and flexible coupling may prevent adverse alterations in on-rate of GPIbalpha for vWF-A1, and permit adaptation to structural differences in GPIbalpha and vWF in several prey species.

Legend

Protein

Chemical

Disease

Primary Citation of related structures